Document is current

Any future updates will be listed below

Identifying subgroups deriving the most benefit from PD-1 checkpoint inhibition plus chemotherapy in advanced metastatic triple-negative breast cancer: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12957-024-03424-3

Published Online: 2024-12-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark